Nutraceutical Based Therapeutics For Cardiac Hypertrophy An Emphasis On Inhibition Of Carbonic Anhydrase Ii And Sodium Proton Exchanger 1

dc.contributor.guide	J M, Siddesha
dc.coverage.spatial	Life Sciences
dc.creator.researcher	Mahendra M
dc.date.accessioned	2025-12-03T11:19:04Z
dc.date.available	2025-12-03T11:19:04Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered	2020
dc.description.abstract	Available
dc.description.note	Summary 117-120p, References 121-152p
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	i-xx, 1-156
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/677903
dc.language	English
dc.publisher.institution	Life Sciences
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	314
dc.rights	university
dc.source.university	University
dc.subject.keyword	Cardiac hypertrophy, NCX1, NHE1, CA-II, nutraceuticals, Naringin, Angioitensin II
dc.subject.keyword	Life Sciences
dc.title	Nutraceutical Based Therapeutics For Cardiac Hypertrophy An Emphasis On Inhibition Of Carbonic Anhydrase Ii And Sodium Proton Exchanger 1
dc.title.alternative
dc.type.degree	Ph.D.